VAERS reports by lot

GSK Varicella/Shingles lot Y24KE: VAERS reports

89 VAERS reports list lot Y24KE as a GSK Varicella/Shingles vaccine, received between 2018-07-18 and 2020-01-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
89
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8227%
Injection-site / Local reaction6521%
Neurological4013%
Musculoskeletal3712%
Dermatological (non-injection-site)279%
Cardiac / Cardiovascular165%
Gastrointestinal134%
Allergic / Anaphylactic114%
Autoimmune / Immune-mediated72%
Psychiatric / Neuropsychiatric41%
Respiratory31%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California10
Pennsylvania9
Georgia6
New Jersey5
Missouri5
North Carolina4
Ohio4
Massachusetts4
New York4
Texas3
Virginia3
Washington3

Reports by month received

2018-0722
2018-0842
2018-099
2018-102
2018-114
2018-121
2019-012
2019-022
2019-034
2020-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.